BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2517248)

  • 21. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
    Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
    Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal instability in chronic myeloid leukemia: Philadelphia breakpoints are irrespective to spontaneous breakage and fragile sites.
    Fundia AF; Acevedo SH; Larripa IB
    Haematologica; 2000 Oct; 85(10):1104-6. PubMed ID: 11025611
    [No Abstract]   [Full Text] [Related]  

  • 24. Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms.
    Gümüş G; Sunguroğlu A; Tükün A; Sayin DB; Bökesoy I
    Cancer Genet Cytogenet; 2002 Mar; 133(2):168-71. PubMed ID: 11943347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
    Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced expression of aphidicolin-induced common fragile sites in peripheral lymphocyte chromosomes of patients with B-cell chronic lymphocytic leukemia.
    Nayak BN; Ray M
    Cancer Genet Cytogenet; 1989 May; 39(1):99-102. PubMed ID: 2499414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.
    Koldehoff M; Steckel NK; Beelen DW; Elmaagacli AH
    Clin Exp Med; 2006 Mar; 6(1):45-7. PubMed ID: 16550344
    [No Abstract]   [Full Text] [Related]  

  • 28. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
    Middleton D; Diler AS; Meenagh A; Sleator C; Gourraud PA
    Tissue Antigens; 2009 Jun; 73(6):553-60. PubMed ID: 19493232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
    Szabo P; Macera MJ; Verma RS
    Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid peroxidation in leukaemia.
    Ghalaut VS; Ghalaut PS; Singh S
    J Assoc Physicians India; 1999 Apr; 47(4):403-5. PubMed ID: 10778525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of fragile sites in childhood acute lymphoblastic leukemia patients and normal controls.
    Rao PN; Heerema NA; Palmer CG
    Hum Genet; 1988 Aug; 79(4):329-34. PubMed ID: 2970424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
    Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
    Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effect of aphidicolin and ethanol on the induction of common fragile sites.
    Kuwano A; Kajii T
    Hum Genet; 1987 Jan; 75(1):75-8. PubMed ID: 3100418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.
    Glover TW; Berger C; Coyle J; Echo B
    Hum Genet; 1984; 67(2):136-42. PubMed ID: 6430783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer chromosome breakpoints and common fragile sites induced by aphidicolin.
    Hecht F; Glover TW
    Cancer Genet Cytogenet; 1984 Oct; 13(2):185-8. PubMed ID: 6434179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis.
    Rao PN; Heerema NA; Palmer CG
    Hum Genet; 1988 Jan; 78(1):21-6. PubMed ID: 2962925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome fragile sites in Down syndrome patients.
    Tedeschi B; Vernole P; Caporossi D; Nicoletti B
    Am J Med Genet Suppl; 1990; 7():192-4. PubMed ID: 2149945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leukemia and lymphoma].
    Kato M; Ogawa S
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():481-4. PubMed ID: 20979299
    [No Abstract]   [Full Text] [Related]  

  • 39. A guide to fragile sites on human chromosomes.
    Hecht F; Ramesh KH; Lockwood DH
    Cancer Genet Cytogenet; 1990 Jan; 44(1):37-45. PubMed ID: 2104573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New common fragile sites.
    Hecht F; Tajara EH; Lockwood D; Sandberg AA; Hecht BK
    Cancer Genet Cytogenet; 1988 Jul; 33(1):1-9. PubMed ID: 2454726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.